Ro

Startups keep laying off swaths of employees as the downturn continues

It’s nearly been two months since we started this accidental weekly column about layoffs happening within startups. Workforce reductions have impacted startup employees in every massive sector, from

Ro cuts 18% of staff despite narrowing focus, raising additional capital

Ro, a healthcare unicorn that last raised $150 million just months ago at a $7 billion valuation, has cut 18% of its staff to “manage expenses, increase the efficiency of our organization and better

Tusk Venture Partners just closed its third fund with $140M, double its predecessor fund

Tusk Venture Partners, the now six-year-old, New York-based early-stage venture firm co-founded by longtime political strategist Bradley Tusk and former Blackstone director Jordan Nof, has closed its

How close are we to understanding what’s going on?

Hello and welcome back to Equity, TechCrunch’s venture capital-focused podcast where we unpack the numbers and nuance behind the headlines. This week we recorded live, which is always good fun,

Modern Fertility co-founder leaves Ro a year after acquisition

Modern Fertility co-founder Afton Vechery is leaving healthcare unicorn Ro about a year after her company, built alongside co-founder Carly Leahy, was sold for north of $225 million. According to an i

Healthcare unicorn Ro parts ways with top execs after fresh round of funding

A week after healthcare unicorn Ro landed capital from existing investors at a higher valuation, two top executives have parted ways with the company, per an internal email obtained by TechCrunch from

Existing investors double down on Ro at boosted $7 billion valuation

Tech healthcare unicorn Ro announced today that it has raised $150 million exclusively from existing investors, led by ShawSpring Partners, with participation from FirstMark Capital, General Catalyst,

Ro is in talks to acquire at-home sperm storage startup Dadi

Ro, a direct-to-consumer health company valued by its investors at $5 billion, is nearing a deal to acquire at-home sperm storage upstart Dadi, per multiple sources familiar with the unicorn’s busin

The inherent tensions within venture capital

Hello and welcome back to Equity, TechCrunch’s venture capital-focused podcast where we unpack the numbers behind the headlines. This is our Wednesday show, the time of the week when we niche down t

Employees detail rising tensions at Ro as healthcare unicorn struggles to grow beyond first win

Ro, one of the most valuable privately owned health tech startups, isn’t subtle about its mission to deliver vertically integrated, affordable healthcare with consumers in mind. And while a patient-

Bradley Tusk is seizing the moment: ‘We’re investing, we’re incubating, we’ve got SPACs’

Whether or not we’re at some kind of tipping point right now, venture investors, old and new, have done very well in recent years, with their limited partners notching the biggest gains in decad

Oova raises $1.2M to develop a better at-home kit for detecting a woman’s best time to conceive

Oova officially launched its Oova Kit that includes an at-home test that quantitatively measures two hormones, informing a woman — and her doctor — of her fertile days and confirming ovulation.

How one founder navigated a highly personal product category and a major shift in focus

On this week’s episode of Found, we speak to Rob Schutz, co-founder and Chief Growth Officer at Ro. Ro recently raised $500 million, bringing its total raised to date to near $1 billion. The dig

The imbalanced landscape of hormonal health

Hello and welcome back to Equity, TechCrunch’s venture capital-focused podcast, where we unpack the numbers behind the headlines. For this week’s deep dive, Alex, Natasha and Chris dug into the wo

Hormonal health is a massive opportunity: Where are the unicorns?

Hormones are key to solving many health conditions that disproportionately impact women, from diabetes to infertility to mental health challenges.

Ro acquires Modern Fertility in a deal north of $225 million

Ro, a digital elective care and telemedicine provider last valued at $5 billion, announced today that it has acquired Modern Fertility, a reproductive health company founded in 2017. Axios estimates

Stix expands from at-home pregnancy and ovulation tests to UTI products with $3.5M seed

Companies like Ro and Hims have capitalized on the need for more seamless and discreet access to health and wellness products that are part of everyday life. For men. Stix is looking to do the same fo

You can only invest if you promise not to read the fine print, OK?

Hello and welcome back to Equity, TechCrunch’s venture capital-focused podcast, where we unpack the numbers behind the headlines. Natasha and Danny and Alex and Grace were all here to chat th

Ro raises $500M to grow its remote and in-home primary care platform

Healthcare tech startup Ro has raised $500 million to help fuel continued growth of its hybrid telehealth/in-home primary care platform, which also includes a growing pharmacy business as the company

Nutrium app, which links dietitians and patients, raises $4.9M led by Indico Capital

Nutrium, a digital health startup which links dietitians and their patients via an app, has raised a €4.25 million seed round led by Indico Capital Partners, alongside the Social Innovation Fund in
Load More